Effect of Long-Term Exposure to PM2.5 on the Risk of Type 2 Diabetes and Arthritis in Type 2 Diabetes Patients: Evidence from a National Cohort in China.

Chaoqun Liu,Ganxiang Cao,Jieying Li,Shaoyan Lian,Ke Zhao,Ying Zhong,Jiahong Xu,Yumeng Chen,Jun Bai,Hao Feng,Guanhao He,Xiaomei Dong,Pan Yang,Fangfang Zeng,Ziqiang Lin,Sui Zhu,Xinqi Zhong,Wenjun Ma,Tao Liu
DOI: https://doi.org/10.1016/j.envint.2023.107741
IF: 11.8
2023-01-01
Environment International
Abstract:Background: It remains unclear whether type 2 diabetes and the complication of arthritis are causally related to the PM2·5 pollutant. Therefore, we aimed to investigate the associations of long-term PM2·5 exposure with type 2 diabetes and with arthritis in type 2 diabetes patients.Methods: This study used data from the China Health and Retirement Longitudinal Survey (CHARLS) implemented during 2011-2018. The associations were analyzed by Cox proportional hazards regression models, and the population-attributable fraction (PAF) was calculated to assess the burden of type 2 diabetes and arthritis-attributable to PM2·5.Findings: A total of 21,075 participants were finally included, of which 1,382 with newly-diagnosed type 2 diabetes and 1,328 with arthritis during the follow-up. Overall, each 10μg/m3 increment in PM2·5 concentration was significantly associated with an increase in the risk of type 2 diabetes (HR=1·26, 95%CI: 1·22 to 1·31), and the PAF of type 2 diabetes attributable to PM2·5 was 13·54%. In type 2 diabetes patients, each 10μg/m3 increment in PM2·5 exposure was associated with an increase in arthritis (HR=1·42, 95%CI: 1·28 to 1·57), and the association was significantly greater than that (H=1·23, 95%CI: 1·19 to 1·28) in adults without type 2 diabetes. The PAFs of arthritis-attributable to PM2·5 in participants with and without type 2 diabetes were 18·54% and 10·69%, respectively.Interpretation: Long-term exposure to PM2·5 may increase the risk of type 2 diabetes and make type 2 diabetes patients susceptible to arthritis.Funding Information: This study was funded by the National Natural Science Foundation of China (42175181, 81874276, 81773497, and 81903294); Natural Science Foundation of Guangdong Province(2019A1515011264); the Science and Technology Program of Guangzhou (202102080565); and Guangzhou Basic and Applied Basic Research Foundation (202102020120).Declaration of Interests: We declare no competing interests.Ethics Approval Statement: The CHARLS was approved by the Biomedical Ethics Review Committee of Perking University (IRB00001052‐ 11015), and informed consent was obtained from all participants.
What problem does this paper attempt to address?